Hostname: page-component-cd9895bd7-p9bg8 Total loading time: 0 Render date: 2025-01-05T13:51:57.640Z Has data issue: false hasContentIssue false
  • English
  • Français

Effects of probiotics and prebiotics on blood lipids

Published online by Cambridge University Press:  11 January 2019

Gary R. J. Taylor  and
Christine M. Williams
Gary R. J. Taylor
Affiliation:
Hugh Sinclair Unit of Human Nutrition, Department of Food Science and Technology, University of Reading, Reading RG6 6AP, UK
Christine M. Williams
Affiliation:
Hugh Sinclair Unit of Human Nutrition, Department of Food Science and Technology, University of Reading, Reading RG6 6AP, UK
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Since the early work of Mann and Spoerry, probiotics in the form of fermented milk products have been reputed to have cholesterol-lowering properties in humans. However, studies conducted since the early 1970s have produced equivocal findings, with interpretation of the outcomes complicated by use of excessive quantities of product, inadequate sample sizes, failure to control nutrient intake and energy expenditure and variations in baseline blood lipids. More recent studies are of better quality, but fail to provide convincing evidence that ‘live’ fermented milk products have cholesterol-lowering efficacy in man. Future studies using probiotics should ensure adequate sample sizes sufficient to detect relatively small changes in blood cholesterol and should be conducted over longer periods of time. The recent introduction of the concept of prebiotics has directed attention towards the possibility that alterations in gut microflora induced by the fermentation of non-digestible components of the diet may also have the potential to influence systemic lipid metabolism. This possibility has been strengthened by the observation that in animals, dietary oligofructosaccharides cause suppression of hepatic triglyceride and VLDL synthesis, resulting in marked reductions in triglyceride, and to a lesser extent cholesterol, levels. Evidence for similar effects in humans is sparse and more studies are needed, particularly with respect to effects on postprandial triglyceride concentrations.

Keywords

ProbioticsBlood lipidsPrebiotics
Type
Research Article
Information
British Journal of Nutrition , Volume 80 , supplement S2: Pre- and Probiotics: Where are We Today? , October 1998 , pp. S225 - S230
Copyright
Copyright © The Nutrition Society 1998

References

Agerbaek, M, Gerdes, LU & Richelsen, B (1995) Hypocholesterolaemic effect of a new fermented milk product in healthy middle-aged men. European Journal Clinical Nutrition 49, 346–352.Google Scholar
Austin, MA, Breslow, JL, Hennekens, CH, Buring, JE, Willett, WC & Krause, RM (1988) Low density lipoprotein subclass patterns and risk of myocardial infarction. Journal of American Medical Association 260, 1917–1921.Google Scholar
Bazarre, TL, Wu, SL & Yuhas, JA (1983) Total and HDL-cholesterol concentration following yoghurt and calcium supplementation. Nutrition Reports International 28, 1225–1232.Google Scholar
Canzi, E, Brighenti, F, Casiraghi, MC, Del Puppo, E & Ferrari, A (1995) Prolonged consumption of inulin in ready to eat breakfast cereals, effects on intestinal ecosystem, bowel habits and lipid metabolism. Proceedings of the COST 92 Conference ‘Dietary fibre and fermentation in the colon’. Helsinki.Google Scholar
Delzenne, NM, Kok, N, Fiordaliso, MF, Deboyser, DM, Goethels, FM & Roberfroid, MB (1993) Dietary fructooligosaccharides modify lipid metabolism in rats. American Journal of Clinical Nutrition 57, 820S.Google Scholar
Delzenne, NM & Roberfroid, MR (1994) Physiological effects of non-digestible oligosaccharides. Lebensmittel Wissenschaft und Technologie 27, 1–6.Google Scholar
Department of Health (1994) Nutritional Aspects of Cardiovascular Disease. Report on Health and Social Subjects 46. London: HMSO.Google Scholar
Fiordaliso, MF, Kok, N, Desager, JP, Goethels, F, Deboyser, D, Roberfroid, M & Delzenne, N (1995) Oligofructose supplemented diet lowers serum and VLDL concentrations of triglycerides, phospholipids and cholesterol in rats. Lipids 30, 163–167.Google Scholar
Gibson, GR, Beatty, ER, Wang, X & Cummings, JH (1995) Selective stimulation of bifidobacteria in the human colon by oligofructose and inulin. Gastroenterology 108, 975–982.Google Scholar
Gibson, GR & Roberfroid, MB (1994) Dietary modulation of the human colonic microbiota. Introducing the concept of prebiotics. Journal of Nutrition 125, 1401–1412.Google Scholar
Groot, PHE, Van Stiphout, WAHJ, Krauss, XH, Jansen, H, Van Tol, A, Van Ramshorst, E, Chin-On, S, Hofman, A, Cresswell, SR & Havekes, L (1991) Postprandial lipoprotein metabolism in normolipidaemic men with and without coronary artery disease. Arteriosclerosis and Thrombosis 11, 653–662.Google Scholar
Havel, R (1994) McCollum Award Lecture 1993, Triglyceride-rich lipoproteins and atherosclerosis – a new perspective. American Journal Clinical Nutrition 59, 795–799.Google Scholar
Hepner, G, Fried, R, Jeor, SS, Fusetti, L & Morin, R (1979) Hypocholesterolaemic effect of yoghurt and milk. American Journal Clinical Nutrition 32, 19–24.Google Scholar
Hokanson, JE & Austin, MA (1996) Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level, a meta-analysis of population-based prospective studies. Journal of Cardiovascular Risk 3, 213–219.Google Scholar
Howard, AN & Marks, J (1979) Effect of mil products on serum cholesterol. Lancet ii 957.Google Scholar
Jaspers, DA, Massey, LK & Luedecke, LO (1984) Effect of consuming yoghurts prepared with three culture strains on human serum lipoproteins. Journal of Food Science 49, 1178–1181.Google Scholar
Kok, N, Roberfroid, M, Robert, A & Delzenne, N (1996 a) Involvement of lipogenesis in the lower VLDL secretion induced by oligofructose in rats. British Journal of Nutrition 76, 880–891.Google Scholar
Kok, N, Roberfroid, M & Delzenne, N (1996 b) Dietary oligofructose modifies the impact of fructose on hepatic triacylglycerol metabolism. Metabolism 45, 1547–1550.Google Scholar
Law, MR, Wald, NJ & Hackshaw, A (1994) Systematic under-estimation of association between serum cholesterol concentration and ischaemic heart disease in observational studies, data from the BUPA study. British Medical Journal 308, 363–366.Google Scholar
Levine, GN, Keaney, JF & Vita, JA (1995) Cholesterol reduction in cardiovascular disease. Clinical benefits and possible mechanisms. New England Journal Medicine 332, 512–521.Google Scholar
Luo, J, Rizkalla, SW, Alamowitch, C, Boussairi, A, Blayo, A, Barry, J-L, Laffitte, A, Guyon, F, Boraet, FRJ & Slama, G (1996) Chronic consumption of short-chain fructooligosaccharides by healthy subjects decreased basal hepatic glucose production but had no effect on insulin-stimulated glucose metabolism. American Journal Clinical Nutrition 63, 939–945.Google Scholar
McNamara, DJ, Lowell, AE & Sabb, JE (1989) Effect of yoghurt intake on plasma lipid and lipoprotein levels in normolipidemic males. Atherosclerosis 79, 167–171.Google Scholar
Mann, GV (1977) A factor in yoghurt which lowers cholesteremia in man. Atherosclerosis 26, 335–340.Google Scholar
Mann, GV & Spoerry, A (1974) Studies of a surfactant and cholesteremia in the Maasai. American Journal Clinical Nutrition 27, 464–469.Google Scholar
Massay, LK (1984) Effect of changing milk and yoghurt consumption on human nutrient intake and serum lipoproteins. Journal Dairy Science 67, 255–262.Google Scholar
Patsch, W (1992) Relation of triglyceride metabolism and coronary artery disease. Arteriosclerosis and Thrombosis 12, 1336–1345.Google Scholar
Pedersen, A, Sandstrom, B & Van Amelsvoort, JMM (1997) The effect of ingestion of inulin on blood lipids and gastrointestinal symptoms in healthy females. British Journal of Nutrition 78, 215–222.Google Scholar
Richelsen, B, Kristensen, K & Pedersen, SB (1996) Long-term (6 months) effect of a new fermented milk product on the level of plasma lipoproteins – a placebo-controlled and double blind study. European Journal of Clinical Nutrition 50, 811–815.Google Scholar
Rossouw, JE, Burger, EM, Van der Vyver, P & Ferreira, JJ (1981) The effect of skim milk, yoghurt and full cream milk on human serum lipids. American Journal Clinical Nutrition 34, 351–356.Google Scholar
Rumessen, JJ, Bode, S, Hamberg, O & Gudmand-Hoyer, E (1990) Fructans of Jerusalem artichokes, intestinal transport, absorption, fermentation and influence on blood glucose, insulin and C-peptide responses in healthy subjects. American Journal Clinical Nutrition 52, 675–681.Google Scholar
Scandinavian Simvastatin Survival Study Group (1994) Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease. Lancet 344, 1383–1389.Google Scholar
Sessions, VA, Lovegrove, JA, Taylor, GRJ, Dean, TS, Williams, CM, Sanders, TAB, Macdonald, I & Salter, A (1997) The effects of a new fermented milk product on total plasma cholesterol, LDL cholesterol and apolipoprotein B concentrations in middle aged men and women. Proceedings of the Nutrition Society 56, 120A.Google Scholar
Shepherd, J, Cobbe, SM, Ford, I, Isles, CG, Lorimer, AR, Macfarlane, PW, McKillop, JH & Packard, CJ (1995) Prevention of coronary heart disease with pravastatin in men with hypercholesterolaemia. New England Journal of Medicine 333, 1301–7.Google Scholar
Thompson, LU, Jenkins, DJA, Amer, V, Reichert, R, Jenkins, A & Kamulsky, J (1982) The effect of fermented and unfermented milks on serum cholesterol. American Journal Clinical Nutrition 36, 1106–1111.Google Scholar
Yamashita, K, Kawai, K & Itakura, M (1984) Effects of fructooligosaccharides on blood glucose and serum lipids in diabetic subjects. Nutrition Research 4, 961–966.Google Scholar